# Nitric Oxide Control of Migrating Motor Complex: L-NMMA Effects in Relation to Receptor Blockades

> **NCT02245165** · PHASE1 · COMPLETED · sponsor: **Uppsala University** · enrollment: 29 (actual)

## Conditions studied

- Gastrointestinal Motility Disorder
- Disturbance of Salivary Secretion

## Interventions

- **BIOLOGICAL:** L-Nitro-Monomethyl-Arginine (LNMMA) 10 mg/kg IV
- **BIOLOGICAL:** saline

## Key facts

- **NCT ID:** NCT02245165
- **Lead sponsor:** Uppsala University
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-06
- **Primary completion:** 2014-05
- **Final completion:** 2014-05
- **Target enrollment:** 29 (ACTUAL)
- **Last updated:** 2014-09-19

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02245165

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02245165, "Nitric Oxide Control of Migrating Motor Complex: L-NMMA Effects in Relation to Receptor Blockades". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02245165. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*